• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Are patients with systemic lupus erythematosus at increased risk for COVID-19?

作者信息

Favalli Ennio Giulio, Gerosa Maria, Murgo Antonella, Caporali Roberto

机构信息

Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia, Italy

Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia, Italy.

出版信息

Ann Rheum Dis. 2021 Feb;80(2):e25. doi: 10.1136/annrheumdis-2020-217787. Epub 2020 May 25.

DOI:10.1136/annrheumdis-2020-217787
PMID:32451344
Abstract
摘要

相似文献

1
Are patients with systemic lupus erythematosus at increased risk for COVID-19?系统性红斑狼疮患者感染新型冠状病毒肺炎的风险会增加吗？
Ann Rheum Dis. 2021 Feb;80(2):e25. doi: 10.1136/annrheumdis-2020-217787. Epub 2020 May 25.
2
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.系统性红斑狼疮患者基线使用羟氯喹并不排除感染SARS-CoV-2及发生重症新型冠状病毒肺炎。
Ann Rheum Dis. 2020 Oct;79(10):1386-1388. doi: 10.1136/annrheumdis-2020-217690. Epub 2020 May 7.
3
Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.2019年冠状病毒病大流行期间系统性红斑狼疮患者的羟氯喹短缺情况：系统性红斑狼疮国际协作诊所的经验
Ann Rheum Dis. 2021 Feb;80(2):1-2. doi: 10.1136/annrheumdis-2020-218164. Epub 2020 Jun 25.
4
Cyclosporine may reduce the risk of symptomatic COVID-19 in patients with systemic lupus erythematosus: a retrospective cohort study.环孢素可能降低红斑狼疮患者发生有症状 COVID-19 的风险：一项回顾性队列研究。
Microbiol Spectr. 2024 Nov 5;12(11):e0127624. doi: 10.1128/spectrum.01276-24. Epub 2024 Oct 15.
5
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.COVID-19 患者伴系统性红斑狼疮，SARS-CoV-2 RNA 阳性复发后成功康复：病例报告及文献复习。
Clin Rheumatol. 2020 Sep;39(9):2803-2810. doi: 10.1007/s10067-020-05230-0. Epub 2020 Jul 28.
6
Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli .
Ann Rheum Dis. 2021 Feb;80(2):e26. doi: 10.1136/annrheumdis-2020-217859. Epub 2020 May 25.
7
No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: comment by Joob and Wiwanitkit.目前尚无证据表明羟氯喹对预防新冠病毒病具有保护作用：乔布和维瓦尼特基的评论
Ann Rheum Dis. 2021 Feb;80(2):e22. doi: 10.1136/annrheumdis-2020-217665. Epub 2020 May 13.
8
SLE patients are not immune to covid-19: importance of sending the right message across.系统性红斑狼疮患者并非对新冠病毒免疫：传递正确信息的重要性。
Ann Rheum Dis. 2021 Feb;80(2):e23. doi: 10.1136/annrheumdis-2020-217658. Epub 2020 Apr 23.
9
COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients.COVID-19 在系统性红斑狼疮中的表现：一项针对 417 名患者的调查数据。
Semin Arthritis Rheum. 2020 Oct;50(5):1150-1157. doi: 10.1016/j.semarthrit.2020.06.012. Epub 2020 Jun 30.
10
Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.2019年冠状病毒病大流行期间羟氯喹短缺对系统性红斑狼疮患者的潜在后果
J Rheumatol. 2020 Jun 1;47(6):787-790. doi: 10.3899/jrheum.200395. Epub 2020 Apr 8.

引用本文的文献

1
Exploring the complex relationship between systemic lupus erythematosus and coronavirus disease 2019: genetic insights and potential protective mechanisms.探索系统性红斑狼疮与2019冠状病毒病之间的复杂关系：遗传学见解与潜在保护机制。
J Glob Health. 2025 Jul 11;15:04191. doi: 10.7189/jogh.15.04191.
2
Healthcare Encounters and Outcomes of Filipino Patients with Systemic Lupus Erythematosus Managed at a Tertiary COVID-19 Referral Center.在一家三级 COVID-19 转诊中心接受治疗的菲律宾系统性红斑狼疮患者的医疗遭遇与治疗结果
Acta Med Philipp. 2024 Feb 15;58(2):27-35. doi: 10.47895/amp.vi0.5767. eCollection 2024.
3
COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology.
COVID-19 预后在系统性红斑狼疮与类风湿关节炎和脊柱关节炎中的比较：来自意大利风湿病学会的 CONTROL-19 研究的结果。
Lupus Sci Med. 2023 Oct;10(2). doi: 10.1136/lupus-2023-000945.
4
Systemic Lupus Erythematosus and COVID-19.系统性红斑狼疮与 COVID-19。
Curr Rheumatol Rep. 2023 Oct;25(10):192-203. doi: 10.1007/s11926-023-01110-z. Epub 2023 Jul 21.
5
No genetic causal association between systemic lupus erythematosus and COVID-19.系统性红斑狼疮与 COVID-19 之间不存在遗传因果关联。
Front Immunol. 2023 May 18;14:1183570. doi: 10.3389/fimmu.2023.1183570. eCollection 2023.
6
Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study.未接种疫苗和接种疫苗的系统性红斑狼疮患者 COVID-19 风险：一项基于普通人群的研究。
RMD Open. 2023 Mar;9(1). doi: 10.1136/rmdopen-2022-002839.
7
Non-causal association of COVID-19 with systemic lupus erythematosus: Evidence from a bidirectional Mendelian randomization.2019冠状病毒病与系统性红斑狼疮的非因果关联：来自双向孟德尔随机化的证据
J Infect. 2023 Apr;86(4):e87-e90. doi: 10.1016/j.jinf.2023.02.028. Epub 2023 Feb 21.
8
Are patients with systemic lupus erythematosus at increased risk for COVID-19? A bi-directional Mendelian randomisation study.系统性红斑狼疮患者感染新型冠状病毒肺炎的风险是否增加？一项双向孟德尔随机化研究。
Lupus Sci Med. 2022 Aug;9(1). doi: 10.1136/lupus-2022-000786.
9
Humoral and cellular response in convalescent COVID-19 lupus patients.恢复期 COVID-19 狼疮患者的体液和细胞反应。
Sci Rep. 2022 Aug 12;12(1):13787. doi: 10.1038/s41598-022-17334-5.
10
Systems biology models to identify the influence of SARS-CoV-2 infections to the progression of human autoimmune diseases.用于确定新型冠状病毒感染对人类自身免疫性疾病进展影响的系统生物学模型。
Inform Med Unlocked. 2022;32:101003. doi: 10.1016/j.imu.2022.101003. Epub 2022 Jul 6.